-
Bristol-Myers Squibb (BMY) Extends Strategic Partnership with TARGET PharmaSolutions for TARGET-NASH
Oct 12, 2017, 11:24 AM by Michael CroftCHAPEL HILL, NC - Oct 12, 2017 - TARGET PharmaSolutions, Inc., a real-world clinical data company, is pleased to announce that Bristol-Myers Squibb (BMY) has extended its strategic partnership for TARGET-NASH to a multi-year agreementFull story -
FDA Vote Sets Stage For Gene Therapy’s Future
Oct 12, 2017, 09:14 AM by Michael CroftMIT Technology Review | A first-of-its-kind medical treatment that replaces a mutated gene with a correct copy could soon be available in the U.S.Full story -
Elsevier donates Unified Data Model to The Pistoia Alliance, facilitating data sharing and accelerating research in the life sciences
Oct 12, 2017, 05:03 AM by Michael CroftNEW YORK, NY - Oct 10, 2017 - Elsevier, the information analytics business specializing in science and health, has announced it is donating its Unified Data Model (UDM) to The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life sciences R&DFull story -
MDI Biological Laboratory Scientist Vicki P. Losick, Ph.D., Recognized As ‘Outstanding Investigator’
Oct 11, 2017, 15:49 PM by Michael CroftBAR HARBOR, ME, UNITED STATES - Oct 11, 2017 - Vicki P. Losick, Ph.D., of the MDI Biological Laboratory in Bar Harbor, Maine, has been recognized as an outstanding investigator by the National Institute of General Medical Sciences, an institute of the National Institutes of Health (NIH), for her research on wound healingFull story -
The Future Of DNA Sequencing
Oct 11, 2017, 13:26 PM by Michael CroftNature News & Comment | Eric D. Green, Edward M. Rubin, and Maynard V. Olson speculate on the next forty years of DNA sequencing, from policing to data storage.Full story -
What The EU General Data Protection Regulation Means For You
Oct 10, 2017, 09:15 AM by Michael CroftFull storyBio-IT World | The European Union’s General Data Protection Regulation goes into effect May 25, 2018. The regulation is significantly more expansive than the privacy directive it replaces and carries hefty financial penalties for non-compliance. But the biggest cause for concern may be its impact for non-European companies, who have no idea that the regulations apply to them.
-
Optibrium Joins EUR 40 Million eTRANSAFE project
Oct 10, 2017, 06:02 AM by Michael CroftCAMBRIDGE, UK - Oct 10, 2017 - Optibrium, a developer of software for small molecule drug discovery, today announced that it will join the Enhancing Translational Safety Assessment through Integrative Knowledge Management (eTRANSAFE) projectFull story -
Launch of Next-Generation Clinical Trial Data Platform
Oct 10, 2017, 01:25 AM by Michael CroftRUTLAND, MA, UNITED STATES - Oct 10, 2017 - A brand new clinical trial database and collaborative platform was launched on the 3rd of October, with the aim of being the leading source for every clinical trial data needFull story -
4D Movies Reveal Two Mechanisms For DNA Loops
Oct 6, 2017, 10:40 AM by Michael CroftFull storyBio-IT World | A paper published yesterday in Cell sheds more light on two mechanisms of DNA folding within the nucleus, and how the folding impacts genome function.
-
Illumina Introduces Nextera DNA Flex
Oct 6, 2017, 08:40 AM by Michael CroftFull storyBio-IT World Brief | Illumina announced the availability of an innovative whole genome sequencing library prep product, Nextera DNA Flex, which eliminates the need for sample preparation for whole blood and saliva, and removes tedious steps in the library prep workflow, such as mechanical fragmentation of DNA, quantification, and normalization.
-
Nature Adds Alert To Heavily Debated Paper About Gene Editing
Oct 5, 2017, 15:05 PM by Michael CroftFull storyRetraction Watch | Nature has added an “editor’s note” to a high-profile paper detailing how a team of researchers used CRISPR-Cas9 gene editing to correct a disease-causing mutation in viable human embryos, alerting readers to the fact that the article has been subject to criticism.
-
Cloud-based Informatics Can Increase Agility, Reduce TCO, Improve Collaboration
Oct 5, 2017, 10:35 AM by Michael CroftFull storyBio-IT World Contributed Commentary | The move to collaborative research is one of the most fundamental changes occurring in life sciences discovery today. As biopharmaceutical companies engage more and more with each other, increased operational agility, reduced total cost of ownership, and improved global collaboration have become important keys to success.
-
Certara Launches Version 8.0 of its Industry-leading Phoenix® PK/PD Modeling and Simulation Software
Oct 5, 2017, 09:39 AM by Michael CroftPRINCETON, NJ - Oct 5, 2017 - Certara®, the global leader in model-informed drug development and regulatory science, today announced the launch of Phoenix 8Full story -
Synthego And Thermo Fisher To Manufacture, Distribute Synthetic Guide RNA Products For CRISPR
Oct 5, 2017, 09:20 AM by Michael CroftFull storyBio-IT World Brief | Synthego announces a new alignment with Thermo Fisher Scientific to manufacture and distribute world-class quality synthetic guide RNA products. Synthego’s synthetic guide RNA portfolio and synthetic guide RNA manufacturing capabilities will be utilized to produce synthetic guide RNAs under Thermo Fisher’s Invitrogen TrueGuide brand that will be marketed and sold across Thermo Fisher channels worldwide.
-
Greenphire Celebrates Site Empowerment at 2017 Global Site Solutions Summit
Oct 5, 2017, 09:09 AM by Michael CroftBOCA RATON, FL, UNITED STATES - Oct 5, 2017 - Greenphire, the global leader in clinical payment automation, and a Global Impact Partner (GIP) of the Society for Clinical Research Sites will celebrate site empowerment and centricity at the 2017 Global Site Solutions Summit taking place in Boca Raton, FloridaFull story -
Tubilux selects TraceLink to achieve EU FMD Compliance
Oct 5, 2017, 07:28 AM by Michael Croft, MA - Oct 5, 2017 - North Reading, MA (October 3, 2017)—TraceLink Inc., the worlds largest track and trace network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, today announced that Tubilux has selected its serialization solutions to help its 30+ European pharmaceutical manufacturing customers comply with the rapidly approaching serialization deadlines for the EU Falsified Medicines Directive (FMD)Full story -
Why Science Turned On Craig Venter For Championing Genetic Privacy
Oct 4, 2017, 16:04 PM by Michael CroftInverse | In early September, notorious geneticist and businessman J. Craig Venter published a controversial study claiming that faces and other personal details could be back-engineered from supposedly "private" genetic data. Before most people even got a chance to read his latest paper, the criticisms began rolling.Full story -
HumanCode Gives Couples A DNA-based Glimpse Into Their Future Children
Oct 4, 2017, 08:45 AM by Michael CroftFull storyBio-IT World Brief | HumanCode announced the launch of BABYGlimpse, the first DNA-powered app for couples to discover and explore the genetic-related traits their children may inherit.
-
New ‘Upcycled’ HPC Machine at Durham University Helps Space Science
Oct 4, 2017, 06:59 AM by Michael CroftDURHAM, UNITED KINGDOM - Oct 4, 2017 - Researchers specialising in astrophysics and cosmology, particle physics and nuclear physics at Durham University and from across the UK can now take advantage of an extended HPC serviceFull story -
Tools Of The 21st Century: HPC, Analytical Ultracentrifugation, And A New Detector
Oct 3, 2017, 14:59 PM by Michael CroftTexas Advanced Computing Center | Researches made a discovery about how the West Nile virus uses cell proteins to facilitate its replication. The research was enabled by HPC, analytical ultracentrifugation, and a new detector.Full story